Bristol ​Myers Squibb lifted its full-year revenue and profit forecast on Thursday as strong sales of blood thinner ‌Eliquis and newer medicines pushed second-quarter results well past analysts' ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results